X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (88) 88
humans (82) 82
pulmonary disease, chronic obstructive - drug therapy (70) 70
respiratory system (70) 70
obstructive pulmonary-disease (65) 65
chronic obstructive pulmonary disease (56) 56
tiotropium (53) 53
lung diseases, obstructive (51) 51
pulmonary disease, chronic obstructive - physiopathology (43) 43
treatment outcome (40) 40
copd (38) 38
double-blind (37) 37
safety (37) 37
administration, inhalation (34) 34
efficacy (34) 34
pulmonary disease, chronic obstructive - diagnosis (33) 33
daily aclidinium bromide (31) 31
bronchodilator agents - administration & dosage (29) 29
bronchodilator agents - therapeutic use (29) 29
muscarinic antagonists - administration & dosage (29) 29
diseases of the respiratory system (28) 28
bronchodilator agents - adverse effects (27) 27
muscarinic antagonists - adverse effects (27) 27
severity of illness index (27) 27
drug therapy (26) 26
lung - physiopathology (26) 26
muscarinic antagonists - therapeutic use (26) 26
pharmacology & pharmacy (26) 26
lung - drug effects (24) 24
international journal of chronic obstructive pulmonary disease (22) 22
once-daily tiotropium (22) 22
quality of life (22) 22
female (21) 21
indacaterol (21) 21
middle aged (21) 21
glycopyrronium (20) 20
male (20) 20
review (20) 20
glycopyrrolate - administration & dosage (19) 19
aged (18) 18
care and treatment (18) 18
copd patients (18) 18
adrenergic beta-2 receptor agonists - therapeutic use (17) 17
drug therapy, combination (17) 17
respiratory tract diseases (17) 17
time factors (17) 17
adrenergic beta-2 receptor agonists - administration & dosage (16) 16
drug combinations (16) 16
forced expiratory volume (16) 16
lama (16) 16
lung-function (16) 16
once-daily indacaterol (16) 16
twice-daily salmeterol (16) 16
aclidinium bromide (15) 15
glycopyrrolate - adverse effects (15) 15
analysis (14) 14
bronchodilators (14) 14
fixed-dose combination (14) 14
long-acting muscarinic antagonist (14) 14
placebo (14) 14
research (14) 14
aclidinium bromide/formoterol fumarate (13) 13
disease progression (13) 13
exacerbations (13) 13
original research (13) 13
umeclidinium/vilanterol 62.5/25 mcg (13) 13
aclidinium (12) 12
bronchodilation (12) 12
clinical trials (12) 12
dosage and administration (12) 12
drug administration schedule (12) 12
glycopyrrolate (12) 12
glycopyrrolate - therapeutic use (12) 12
inhaled corticosteroids (12) 12
randomized controlled trials as topic (12) 12
recovery of function (12) 12
adrenergic beta-2 receptor agonists - adverse effects (11) 11
formoterol (11) 11
mortality (11) 11
once-daily nva237 (11) 11
pharmacological characterization (11) 11
pulmonary and respiratory medicine (11) 11
respiratory agents (11) 11
risk factors (11) 11
to-severe copd (11) 11
asthma (10) 10
bronchodilator (10) 10
exercise tolerance (10) 10
fixed-dose combinations (10) 10
health aspects (10) 10
laba (10) 10
patient outcomes (10) 10
tiotropium bromide (10) 10
double-blind method (9) 9
dyspnea (9) 9
long-acting bronchodilators (9) 9
lung diseases (9) 9
medicine, general & internal (9) 9
muscarinic antagonists (9) 9
muscarinic antagonists - pharmacology (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2017, Volume 12, pp. 1731 - 1740
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 09/2013, Volume 8, pp. 405 - 423
Journal Article
Advances in Therapy, ISSN 0741-238X, 3/2019, Volume 36, Issue 3, pp. 495 - 519
Maintenance bronchodilator therapy with long-acting β-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) is the cornerstone treatment for patients... 
Indacaterol/glycopyrronium | Rheumatology | Internal Medicine | Oncology | Olodaterol/tiotropium | Medicine & Public Health | Asia | Fixed-dose combination | Formoterol/aclidinium | Vilanterol/umeclidinium | Long-acting muscarinic antagonists | Long-acting β-agonists | Chronic obstructive pulmonary disease | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | Long-acting beta-agonists | PHARMACOLOGICAL CHARACTERIZATION | QVA149 INDACATEROL/GLYCOPYRRONIUM | OBSTRUCTIVE PULMONARY-DISEASE | ACLIDINIUM BROMIDE | 5 MU-G | ONCE-DAILY INDACATEROL | TWICE-DAILY SALMETEROL | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | JAPANESE PATIENTS | CHINESE PATIENTS | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - adverse effects | Muscarinic Antagonists - therapeutic use | Benzyl Alcohols - therapeutic use | Indans - therapeutic use | Quinuclidines - therapeutic use | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Tiotropium Bromide - therapeutic use | Bronchodilator Agents - adverse effects | Formoterol Fumarate - therapeutic use | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Tropanes - therapeutic use | Benzoxazines - therapeutic use | Muscarinic Antagonists - administration & dosage | Asian Continental Ancestry Group | Chlorobenzenes - therapeutic use | Adrenergic beta-2 Receptor Agonists - administration & dosage | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | aclidinium | umeclidinium | Indacaterol | Review | tiotropium | Vilanterol | Formoterol | glycopyrronium | Olodaterol
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 05/2017, Volume 195, Issue 9, pp. 1189 - 1197
Journal Article